Effect of pregnancy on topiramate pharmacokinetics in rabbits

References

• Anderson GD. (2005). Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989–1008.
   PubMed Web of Science ®Google Scholar
• Battino D, Tomson T. (2007). Management of epilepsy during pregnancy. Drugs 67:2727–2746.
   PubMed Web of Science ®Google Scholar
• Brodtkorb E, Reimers A. (2008). Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure 17:160–165.
   PubMed Web of Science ®Google Scholar
• Caldwell GW, Wu WN, Masucci JA, McKown LA, Gauthier D, Jones WJ, Leo GC, Maryanoff BE. (2005). Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans. Eur J Drug Metab Pharmacokinet 30:151–164.
   PubMed Web of Science ®Google Scholar
• Chamberlain A, White S, Bawdon R, Thomas S, Larsen B. (1993). Pharmacokinetics of ampicillin and sulbactam in pregnancy. Am J Obstet Gynecol 168:667–673.
   PubMed Web of Science ®Google Scholar
• Davison JM, Dunlop W, Ezimokhai M. (1980). 24-hour creatinine clearance during the third trimester of normal pregnancy. Br J Obstet Gynaecol 87:106–109.
   PubMedGoogle Scholar
• Garnett W. (2000). Clinical pharmacology of topiramate: a review. Epilepsia 41(Suppl 1):S61–S65.
   PubMedGoogle Scholar
• Gidal BE, Lensmeyer GL. (1999). Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method. Ther Drug Monit 21:567–576.
   PubMedGoogle Scholar
• Heikkilä A, Erkkola R. (1991). Pharmacokinetics of piperacillin during pregnancy. J Antimicrob Chemother 28:419–423.
   PubMed Web of Science ®Google Scholar
• Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J, Craig J; UK Epilepsy and Pregnancy Register. (2008). Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71:272–276.
   PubMed Web of Science ®Google Scholar
• Kjellström S, Bruun A, Isaksson B, Eriksson T, Andréasson S, Ponjavic V. (2006). Retinal function and histopathology in rabbits treated with topiramate. Doc Ophthalmol 113:179–186.
   PubMed Web of Science ®Google Scholar
• Lander CM, Eadie MJ. (1991). Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 32:257–266.
   PubMed Web of Science ®Google Scholar
• Langtry HD, Gillis JC, Davis R. (1997). Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 54:752–773.
   PubMed Web of Science ®Google Scholar
• Loebstein R, Lalkin A, Koren G. (1997). Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33:328–343.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA, Yang LP. (2007). Topiramate: a review of its use in the treatment of epilepsy. Drugs 67:2231–2256.
   PubMed Web of Science ®Google Scholar
• Matar KM. (2010). Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry. Clin Chim Acta 411:729–734.
   PubMedGoogle Scholar
• Michelucci R, Passarelli D, Riguzzi P, Volpi L, Tassinari C. (1998). The preclinical and therapeutic activity of the novel anticonvulsant topiramate. CNS Drug Rev 4:165–186.
   Google Scholar
• Ohman I, Sabers A, de Flon P, Luef G, Tomson T. (2009). Pharmacokinetics of topiramate during pregnancy. Epilepsy Res 87:124–129.
   PubMedGoogle Scholar
• Ohman I, Vitols S, Luef G, Söderfeldt B, Tomson T. (2002). Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 43:1157–1160.
   PubMed Web of Science ®Google Scholar
• Pennell PB. (2003). Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61:S35–S42.
   Google Scholar
• Philipson A, Stiernstedt G. (1982). Pharmacokinetics of cefuroxime in pregnancy. Am J Obstet Gynecol 142:823–828.
   PubMed Web of Science ®Google Scholar
• Sabers A, Tomson T. (2009). Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 22:157–161.
   PubMed Web of Science ®Google Scholar
• Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M. (2002). Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients. Epilepsia 43:691–696.
   PubMed Web of Science ®Google Scholar
• Shank R, Gardocki J, Streeter A, Maryanoff B. (2000). An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(Suppl 1):S3–S9.
   PubMedGoogle Scholar
• Tomson T. (2005). Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding. Ther Drug Monit 27:718–721.
   PubMed Web of Science ®Google Scholar
• Tomson T, Battino D. (2007). Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 46:209–219.
   PubMed Web of Science ®Google Scholar
• Westin AA, Nakken KO, Johannessen SI, Reimers A, Lillestølen KM, Brodtkorb E. (2009). Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia 50:480–485.
   PubMed Web of Science ®Google Scholar
• Westin AA, Reimers A, Helde G, Nakken KO, Brodtkorb E. (2008). Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure 17:192–198.
   PubMed Web of Science ®Google Scholar
• Wu W, Heebner J, Streeter A, Moyer M, Takacs A. (1994). Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant, topiramate in healthy men. Pharm Res 11(Suppl):S336.
   Google Scholar